Home » Market News » DirectorsTalk Highlights » BIO International Convention
Avacta Group Plc

BIO International Convention

Over 18,000 leaders in Biotech and Pharma attended the 2018 BIO convention. This year the Avacta team will be exhibiting and will be found on booth 3559. Further information about the event can be found here.

Avacta Group Plc (LON:AVCT) principal focus is on its proprietary Affimer® technology which is a novel engineered alternative to antibodies that has wide application in Life Sciences for diagnostics, therapeutics and general research and development.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.